| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 08/17/2006 | WO2006086705A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists |
| 08/17/2006 | WO2006085815A1 Thiazole derivatives, their process for their preparation and their use in therapy |
| 08/17/2006 | WO2006085510A1 Remedy for irritable bowel syndrome |
| 08/17/2006 | WO2006085108A1 Awthranilic acid derivatives and their use in treatment of diseases of lipid metabolism, in particular dyslipidaemia |
| 08/17/2006 | WO2006070349A3 Novel process for preparing pramipexole and its optical isomeric mixture by reduction with sodium triacetoxyborohydride |
| 08/17/2006 | WO2005107762A3 Certain chemical entities, compositions, and methods |
| 08/17/2006 | WO2005037845A8 Benzothiazole and thiazole[5,5-b] pyridine compositions and their use as ubiquitin ligase inhibitors |
| 08/17/2006 | US20060183918 Beta 2-adrenergic receptor agonists |
| 08/17/2006 | US20060183915 reacting a 1-halo, mesylate, or tosylate-4,4-difluorobutene with a thiocyanate, giving a butenylthiocyanate; converting to a dithiocarbamate by reacting with hydrogen sulfide; condensation and cyclization with (chloro)acetaldehyde; circumvents 2-mercapto-1,3-thiazole intermediate; by-product inhibition |
| 08/17/2006 | US20060183914 reacting a 1-halo, mesylate, or tosylate-4,4-difluorobutene with a thiocyanate, giving a butenylthiocyanate; converting to a dithiocarbamate by reacting with hydrogen sulfide; condensation and cyclization with (chloro)acetaldehyde; circumvents 2-mercapto-1,3-thiazole intermediate; by-product inhibition |
| 08/17/2006 | US20060183913 N-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-formamide for example; compound forms a naturally occurring metabolite when NO is released to slow or prevent drug tolerance; treating cardiovascular diseases, inflammation, psychiatric and neurological diseases, respiratory diseases, urogenital disorders |
| 08/17/2006 | US20060183912 1,4-Bis-[4-Methyl-5-(2-nitrooxy)-ethyl)-thiazol-2-yl]-butane for example; forms a naturally occurring metabolite is formed when nitric oxide is released; treating for example cardiovascular diseases, inflammation, psychiatric and neurological diseases, respiratory diseases, urogenital disorders |
| 08/17/2006 | US20060183805 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 08/17/2006 | US20060183783 2-[3-(2-cyclopentanecarbonyl-4-methyl-phenyl)-ureido]-thiazol-4-yl} acetic acid; 2-[3-(4-Methyl-2-[2-methylpropoxy] phenyl)-ureido]-thiazol-4-yl}-acetic acid; activators of glucokinase; treatment of metabolic disorders, hyperglycemic agent, syndrome x, anticholesterol, hypertension etc. |
| 08/17/2006 | US20060183781 Novel thiazolylmethyl pyrazoles, method for the production thereof, and use thereof in dyes for keratin fibers |
| 08/17/2006 | US20060183718 Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof |
| 08/17/2006 | US20060183177 For detection of caspases, trypsin and tryptase; comprises luciferase and amino-modified aminoluciferin or a carboxy-terminal protected derivative; solid phase synthesis |
| 08/17/2006 | CA2598429A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists |
| 08/16/2006 | EP1689726A1 5-(benz- (z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents |
| 08/16/2006 | EP1689716A1 Biaryl sulfonamides and methods for using same |
| 08/16/2006 | EP1689706A2 Alpha, beta-unsaturated sulfoxides for treating proliferative disorders |
| 08/16/2006 | EP1689391A2 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases |
| 08/16/2006 | EP1689380A2 Method for treating adamts-5-associated disease |
| 08/16/2006 | EP1689231A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 08/16/2006 | EP1583752B1 Cyclization process for substituted benzothiazole derivatives |
| 08/16/2006 | EP1397488B1 Novel compounds for chemiluminescense procedures |
| 08/16/2006 | EP1191019B1 Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof |
| 08/16/2006 | EP1087941B1 Thiolesters and uses thereof |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | CN1269801C Amino acid derivatives and drug containing the same as the active ingredient |
| 08/16/2006 | CN1269528C Application of dipeptide base peptidase IV effector for reducing blood sugar level of mammal |
| 08/15/2006 | US7091380 Bradykinin B1 antagonists or inverse agonists, for prophylaxis and therapy of pain and inflammation |
| 08/15/2006 | US7091360 Reacting nitrogen compounds such as benzoxazole, with grignard reagents to form chemical intermediates used to form cysteine protease inhibitors |
| 08/15/2006 | US7091359 Process for the preparation of thiazolidinedione derivatives |
| 08/15/2006 | US7091242 Beta-amino acid derivatives as integrin receptor antagonists |
| 08/15/2006 | US7091228 4-[4'-(1,3-Benzothiazol-2-ylamino)-1,1'-biphenyl-4-yl]-2,2-dimethyl-4-oxobutanoic acid and derivatives; inhibition of DGAT-1 (diacylglycerol O-acyltransferase type 1) |
| 08/15/2006 | US7091227 Serine/threonine and tyrosine kinases inhibitors |
| 08/15/2006 | US7091225 Substituted oxazoles and thiazoles as hPPAR alpha agonists |
| 08/15/2006 | US7091223 Autoimmune diseases; anticancer agents |
| 08/15/2006 | US7091219 Administering an effective amount of bis-sulfonamide hydroxyethyl-amino derivative to a HIV patient to prevent the viral replication |
| 08/10/2006 | WO2006083781A1 Antidiabetic bicyclic compounds |
| 08/10/2006 | WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/10/2006 | WO2006082952A1 Amide compound |
| 08/10/2006 | WO2006082495A1 Peroxisome proliferator activated receptor modulators |
| 08/10/2006 | WO2006082107A1 Thiazolidinones for use as inhibitors of polo-like kinase (plk) |
| 08/10/2006 | WO2006066778A3 Novel heteroarylacetamides |
| 08/10/2006 | US20060178429 2-Phenyl-3-hydrogenated furanyl, pyranyl, thiophenyl or thiopyranyl-N-heteroaromatic propionamides, e.g., 2-(3,4-Dichloro-phenyl)-3-(tetrahydro-pyran-2-yl)-N-thiazol-2-yl-propionamide; compounds increase insulin secretion in the treatment of type II diabetes. |
| 08/10/2006 | US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease |
| 08/10/2006 | US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents |
| 08/10/2006 | US20060177621 O-coordinated metal chelates and their use in optical recording media having high storage capacity |
| 08/10/2006 | DE102005005813A1 New thiazolo-indazole derivatives useful as PI3 kinase inhibitors, for treating e.g. cancer and other proliferative diseases, viral infections and inflammatory, autoimmune, skin and bone diseases |
| 08/10/2006 | CA2596967A1 Thiazolidinones for use as inhibitors of polo-like kinase (plk) |
| 08/10/2006 | CA2593858A1 Antidiabetic bicyclic compounds |
| 08/10/2006 | CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/09/2006 | EP1688138A1 Receptor function regulating agent |
| 08/09/2006 | EP1687287A1 A novel process for ezetimibe intermediate |
| 08/09/2006 | EP1687285A1 Thiazole and pyrazole derivatives as flt-3 kinase inhibitors |
| 08/09/2006 | EP1687021A1 Method of removing transition metals, especially from metathesis reaction products |
| 08/09/2006 | EP1455779B1 Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 08/09/2006 | CN1816532A Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents |
| 08/09/2006 | CN1816531A Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 08/08/2006 | US7087761 Cyclic thiourea and acetylthiourea derivatives of benzothiazole for drugs |
| 08/08/2006 | US7087644 Cardiovascular disorders; stimulant of guanylate cyclase ; therapy for liver fibrosis |
| 08/08/2006 | US7087623 Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof |
| 08/08/2006 | US7087614 Pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 08/08/2006 | US7087610 Aids therapy |
| 08/08/2006 | US7087604 Antiarthritic agents;multiple sclerosis; anticholesterol agents; cardiovascular disorders |
| 08/08/2006 | US7087593 Psychological disorder treatments that increase the activity of cholinergic receptors |
| 08/08/2006 | US7087229 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 08/08/2006 | CA2200707C Novel prostaglandin synthase inhibitors |
| 08/08/2006 | CA2188835C Novel compounds and methods for synthesis and therapy |
| 08/03/2006 | WO2006081165A1 Improved process for preparing (dihalopropenyl)phenylakeyl substituted benzoxazoles |
| 08/03/2006 | WO2006080407A1 Ppar-activating compound |
| 08/03/2006 | WO2006080406A1 Tricyclic compounds |
| 08/03/2006 | WO2005060456A8 Method for treating adamts-5-associate disease |
| 08/03/2006 | WO2003072033A3 Common ligand mimics: thiazolidinediones and rhodanines |
| 08/03/2006 | US20060173190 Nematicidal thiazoline-containing fluorobutenes |
| 08/03/2006 | US20060173075 P-(sulfonyl) aryl and heteroarylamines-as anti-inflammatory agents |
| 08/03/2006 | US20060173044 Substituted propargylamines |
| 08/03/2006 | US20060173013 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 08/03/2006 | US20060172990 Antibacterial agents |
| 08/03/2006 | US20060172936 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections |
| 08/03/2006 | CA2593803A1 Thiazole-amide compounds and compsitions as protein kinase inhibitors |
| 08/02/2006 | EP1686114A1 Process for producing optically active 2-alkylcysteine, derivative thereof, and processes for production |
| 08/02/2006 | EP1685119A1 N-acylsulfonamide apoptosis promoters |
| 08/02/2006 | EP1685118A2 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 08/02/2006 | EP1685095A1 Method for the production of organic salts containing bis(perfluoroalkyl)phosphinate anions |
| 08/02/2006 | EP1684762A2 Urea derivatives as kinase modulators |
| 08/02/2006 | EP1684745A2 Hepatitis c virus inhibitors |
| 08/02/2006 | EP0986551B1 Sulfonamide derivatives, their production and use |
| 08/02/2006 | CN1812978A Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 08/02/2006 | CN1812977A Substituted carboxylic acids |
| 08/02/2006 | CN1812966A N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides |
| 08/02/2006 | CN1812959A Method for producing difluoro-acetyl-acetic acid alkylesters |
| 08/02/2006 | CN1812956A Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
| 08/02/2006 | CN1810791A Synthesis process of medicine for treating hemopathy |
| 08/02/2006 | CN1267418C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 08/01/2006 | US7084170 Antitumor agents for treating a tumor of the colon or rectum in a mammal; N-[2,4-dichlorobenzoyl]-5-bromothiophene-2-sulfonamide sodium salt |
| 08/01/2006 | US7084166 Such as 1,1-di-(N-benzyl-indol-3-yl)-1-butene; for drug resistant tumors |
| 08/01/2006 | US7084162 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |